Squarepoint’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$75.3K Buy
+11,208
New +$75.3K ﹤0.01% 2544
2024
Q4
Sell
-41,568
Closed -$664K 3224
2024
Q3
$664K Buy
41,568
+15,618
+60% +$250K ﹤0.01% 1630
2024
Q2
$370K Sell
25,950
-8,151
-24% -$116K ﹤0.01% 1867
2024
Q1
$483K Buy
+34,101
New +$483K ﹤0.01% 1682